These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3811318)

  • 21. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of septic pelvic thrombophlebitis by measurement of fibrinopeptide A.
    Weiner CP; Kwaan H; Duboe F
    Am J Perinatol; 1985 Apr; 2(2):93-5. PubMed ID: 4096764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays.
    Nossel HL; Butler VP; Wilner GD; Canfield RE; Harfenist EJ
    Thromb Haemost; 1976 Feb; 35(1):101-9. PubMed ID: 60791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility and temporal stability of ADP-induced platelet aggregation: comparison of the anticoagulants sodium citrate and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone.
    Horne WC; Anderson GM; Cohen DJ
    Am J Hematol; 1991 Sep; 38(1):48-53. PubMed ID: 1897514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G; Roux A; Haeberli A; Straub PW
    Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance characteristics of a simple radioimmunoassay for fibrinopeptide A.
    Walenga JM; Hoppensteadt D; Emanuele RM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):219-27. PubMed ID: 6515418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturition.
    Wallmo L; Karlsson K; Teger-Nilsson AC
    Acta Obstet Gynecol Scand; 1984; 63(7):637-40. PubMed ID: 6516813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
    J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of plasma quality as raw material for factor VIII:C concentrates. Storage of whole blood and plasma and interindividual plasma levels of fibrinopeptide A.
    Carlebjörk G; Blombäck M; Akerblom O
    Vox Sang; 1983; 45(3):233-42. PubMed ID: 6414186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics.
    Ishii M; Kameyama M; Inokuchi T; Isogai S
    Diabetes Res Clin Pract; 1987 Nov; 4(1):45-50. PubMed ID: 3319468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF; Schreiler WE; Bell WR
    Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans.
    Ceriello A; Giugliano D; Quatraro A; Dello Russo P; Marchi E; Torella R
    Metabolism; 1989 Dec; 38(12):1162-3. PubMed ID: 2593829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.